Futurity: Research NewsHow to brew hoppy beer, no hops requiredFuturity: Research NewsDenby came to UC Berkeley to work on sustainable transportation fuels with Jay Keasling, a pioneer in the field of synthetic biology and a professor of chemical and b… Continue reading
Bio-IT World |
CRISPR Strategy & Standards: How Synthego’s Free Software Lays The Groundwork For CRISPR Futures
Bio-IT World March 21, 2018 | “Science really moves forward when things become easier to the scientist: when you don’t have to spend as much time doing something, or a new capability comes on the scene,” says Paul Dabrowski, CEO and co-founder of Synthego. CRISPR … |
Times of Malta |
Blood cancer survivor meets ‘genetic twin’ stem cell donor
Times of Malta Peter Milburn and Aysha Lord at the charity’s Let’s Make a Spark Award ceremony, as the father of four who survived blood cancer has met and thanked the “genetic twin” stem cell donor who saved his life. A father of four who survived blood cancer has … Blood cancer survivor meets `genetic twin´ stem cell donorInfosurhoy |
PR Newswire (press release) |
BioMarin’s Gene Therapy Manufacturing Facility Recognized with Industry Award
PR Newswire (press release) SAN RAFAEL, Calif., March 21, 2018 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the International Society for Pharmaceutical Engineering (ISPE) selected the company’s gene therapy manufacturing facility as the 2018 … |
Multiple Sclerosis News Today |
Blood Stem Cell Transplants Improve RRMS Patients’ Disability, Phase 3 Trial Shows
Multiple Sclerosis News Today Blood stem cell transplants lead to significant improvements in relapsing-remitting multiple sclerosis patients’ disability, a Phase 3 clinical trial shows. The 110 patients who took part in the MIST study (NCT00273364) were having relapses after … |
Multiple Sclerosis News Today |
Blood Stem Cell Transplants Improve RRMS Patients’ Disability, Phase 3 Trial Shows
Multiple Sclerosis News Today Blood stem cell transplants lead to significant improvements in relapsing-remitting multiple sclerosis patients’ disability, a Phase 3 clinical trial shows. The 110 patients who took part in the MIST study (NCT00273364) were having relapses after … |
OregonLive.com |
PRP and stem cell: Can civilians now heal more like professional athletes?
OregonLive.com “When platelets are around they recruit stem cells in the area to help re-build damaged tissue. In the knee, because there’s no flood flow in cartilage and there are very few stem cells resident in the knee joint, platelets will shut down inflammatory … |